BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Incyte
Pharmaceuticals
Inc.
Incyte
Pharmaceuticals
Inc.
Incyte's gene
expression microarray
technology for
functional genomics
applications in plant,
animal and human
genomes
Incyte's LifeTools
software and plant
sequences
3-year, large-scale,
genome-wide
agreement--
Monsanto gets
access to up to 50K
DNA microarrays
for use across its
life science
programs, Incyte
will provide data
from custom and
prefabricated DNA
microarrays,
software to manage
and analyze data
and consulting
services
broad-based
genomics and
software licensing
agreement (9/96),
expanded to include
LifeSeq®, LifeSeq
FL®, LifeSeq
Atlas, LifeSeq
GeneAlbum
cDNA, PathoSeq
and ZooSeq
Copyright ©2006 AHC Media ® 251
5/98
10/97
Japan Tobacco high-yield rice joint development 12/95
Inc.
agreement
Mendel
Monsanto to
partnership, 1997
Biotechnology Inc. commercialize
expanded and
technologies developed extended through
by Mendel, both
companies will develop
an integrated framework
for predictive control of
plant gene expression
2011 (7/06)
Mexican Ministry genetically engineered R&D agreement 7/93
of Agriculture and potato to resist viral
Water Resources diseases
Millennium Millennium's genomics 5-year, $218M 10/97
Pharmaceuticals technology platform to agreement--
Inc.
develop agricultural Monsanto to pay
products
$118M in licensing
and technology
transfer fees ($38M
up-front, $16M per
year for five years),
Monsanto could pay
an additional
$20M/year in
milestone payments
based on research
objectives,
Monsanto to form
subsidiary in
Cambridge, MA
with 100 scientists,
Millennium retains
right to use
technologies
developed by the
subsidiary for non-